Approval · Notice of Compliance 24942 · 2021
DRONTAL PLUS: Notice of Compliance 24942
Issued January 5, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24942
- Date
- January 5, 2021
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DRONTAL PLUS | 02169517 | Marketed |
Medicinal ingredients
- FEBANTEL 113.4 MG per TAB
- PRAZIQUANTEL 22.7 MG per TAB
- PYRANTEL PAMOATE 22.7 MG per TAB